1,5-Anhydroglucitol as a marker of maternal glycaemic control and predictor of neonatal birthweight in pregnancies complicated by type 1 diabetes mellitus
- PMID: 23377619
- PMCID: PMC3589622
- DOI: 10.1007/s00125-013-2830-3
1,5-Anhydroglucitol as a marker of maternal glycaemic control and predictor of neonatal birthweight in pregnancies complicated by type 1 diabetes mellitus
Abstract
Aims/hypothesis: Most pregnant women with type 1 diabetes mellitus achieve HbA1c targets; however, macrosomia remains prevalent and better pregnancy glycaemic markers are therefore needed. 1,5-Anhydroglucitol (1,5-AG) is a short-term marker of glycaemia, reflecting a period of 1 to 2 weeks. Its excretion rate depends on the renal glucose threshold and thus it is unclear whether it may be used in pregnant type 1 diabetes women. We evaluated 1,5-AG as a glycaemic marker and birthweight predictor in pregnant women with type 1 diabetes, and compared its performance with HbA1c.
Methods: 1,5-AG and HbA1c were measured in 82 pregnant women with type 1 diabetes. In addition, 58 continuous glucose monitoring system (CGMS) records were available. Macrosomia was defined as birthweight >90th centile. The data were analysed with Pearson's correlations, and linear and logistic regression models. Receiver operating characteristic (ROC) analysis was used to evaluate third trimester 1,5-AG as a predictor of macrosomia.
Results: Unlike HbA1c, 1,5-AG strongly correlated with CGMS indices: the AUC above 7.8 mmol/l (r = -0.66; p < 0.001), average maximum glucose (r = -0.58; p < 0.001) and mean glucose (r = -0.54; p < 0.001). In the third trimester, 1,5-AG was the strongest predictor of macrosomia, with ROC AUC 0.81 (95% CI 0.70, 0.89). In contrast, HbA1c in the third trimester had a ROC AUC of 0.69 (95% CI 0.58, 0.81). The best discrimination was achieved when both markers were used jointly, yielding a ROC AUC of 0.84 (95% CI 0.76, 0.93).
Conclusions/interpretation: In pregnant women with type 1 diabetes, 1,5-AG is a better glycaemic marker than HbA1c, as assessed by CGMS. A decreased third trimester 1,5-AG level, either singly or with HbA1c, is a strong predictor of macrosomia.
Figures

Similar articles
-
Addition of intermittently scanned continuous glucose monitoring to standard care in a cohort of pregnant women with type 1 diabetes: effect on glycaemic control and pregnancy outcomes.Diabetologia. 2022 Aug;65(8):1302-1314. doi: 10.1007/s00125-022-05717-2. Epub 2022 May 12. Diabetologia. 2022. PMID: 35546211
-
Sibling birthweight as a predictor of macrosomia in women with type 1 diabetes.Diabetologia. 2005 Sep;48(9):1743-8. doi: 10.1007/s00125-005-1851-y. Epub 2005 Jul 14. Diabetologia. 2005. PMID: 16021414
-
Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomised clinical trial.BMJ. 2008 Sep 25;337:a1680. doi: 10.1136/bmj.a1680. BMJ. 2008. PMID: 18818254 Free PMC article. Clinical Trial.
-
Insulin during pregnancy, labour and delivery.Best Pract Res Clin Obstet Gynaecol. 2011 Feb;25(1):65-76. doi: 10.1016/j.bpobgyn.2010.10.002. Epub 2010 Dec 24. Best Pract Res Clin Obstet Gynaecol. 2011. PMID: 21186142 Review.
-
Continuous glucose monitoring in pregnant women with Type 1 diabetes: benefits for mothers, using pumps or pens, and their babies.Diabet Med. 2018 Apr;35(4):430-435. doi: 10.1111/dme.13585. Epub 2018 Feb 15. Diabet Med. 2018. PMID: 29352491 Review.
Cited by
-
The progress of clinical research on the detection of 1,5-anhydroglucitol in diabetes and its complications.Front Endocrinol (Lausanne). 2024 May 13;15:1383483. doi: 10.3389/fendo.2024.1383483. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38803475 Free PMC article. Review.
-
Maternal lipids associated with large-for-gestational-age birth weight in women with type 1 diabetes: results from a prospective single-center study.Arch Med Sci. 2017 Jun;13(4):753-759. doi: 10.5114/aoms.2016.58619. Epub 2016 Mar 16. Arch Med Sci. 2017. PMID: 28721142 Free PMC article.
-
Biomarkers for Macrosomia Prediction in Pregnancies Affected by Diabetes.Front Endocrinol (Lausanne). 2018 Jul 31;9:407. doi: 10.3389/fendo.2018.00407. eCollection 2018. Front Endocrinol (Lausanne). 2018. PMID: 30108547 Free PMC article. Review.
-
Metrics Beyond Hemoglobin A1C in Diabetes Management: Time in Range, Hypoglycemia, and Other Parameters.Diabetes Technol Ther. 2017 May;19(S2):S16-S26. doi: 10.1089/dia.2017.0029. Diabetes Technol Ther. 2017. PMID: 28541136 Free PMC article. Review.
-
Risk of macrosomia remains glucose-dependent in a cohort of women with pregestational type 1 diabetes and good glycemic control.Endocrine. 2017 Feb;55(2):447-455. doi: 10.1007/s12020-016-1134-z. Epub 2016 Oct 11. Endocrine. 2017. PMID: 27726091 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical